Overview

Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The study is aimed to assess safety of Depelestat treatment, as well as efficacy on prevention and treatment of alveolar inflammation in early pulmonary fibrosis in patients suffering from persistent Acute Respiratory Distress Syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Debiopharm International SA